The Company is developing its MultiStem cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas.
http://www.hispanicbusiness.com/2013/7/29/athersys_to_host_second_quarter_2013.htm
http://www.hispanicbusiness.com/2013/7/29/athersys_to_host_second_quarter_2013.htm
No comments:
Post a Comment